Cargando…
Inihibition of Glycolysis by Using a Micro/Nano-Lipid Bromopyruvic Chitosan Carrier as a Promising Tool to Improve Treatment of Hepatocellular Carcinoma
Glucose consumption in many types of cancer cells, in particular hepatocellular carcinoma (HCC), was followed completely by over-expression of type II hexokinase (HKII). This evidence has been used in modern pharmacotherapy to discover therapeutic target against glycolysis in cancer cells. Bromopyru...
Autores principales: | Hanafy, Nemany A., Dini, Luciana, Citti, Cinzia, Cannazza, Giuseppe, Leporatti, Stefano |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5791121/ https://www.ncbi.nlm.nih.gov/pubmed/29320411 http://dx.doi.org/10.3390/nano8010034 |
Ejemplares similares
-
Polymeric Nano-Micelles as Novel Cargo-Carriers for LY2157299 Liver Cancer Cells Delivery
por: Hanafy, Nemany Abdelhamid Nemany, et al.
Publicado: (2018) -
Nano targeted Therapies Made of Lipids and Polymers have Promising Strategy for the Treatment of Lung Cancer
por: Essa, Marwa Labib, et al.
Publicado: (2020) -
Encapsulating TGF-β1 Inhibitory Peptides P17 and P144 as a Promising Strategy to Facilitate Their Dissolution and to Improve Their Functionalization
por: Hanafy, Nemany A. N., et al.
Publicado: (2020) -
Micelles Structure Development as a Strategy to Improve Smart Cancer Therapy
por: Hanafy, Nemany A. N., et al.
Publicado: (2018) -
Simultaneous Administration of Bevacizumab with Bee-Pollen Extract-Loaded Hybrid Protein Hydrogel NPs Is a Promising Targeted Strategy against Cancer Cells
por: Hanafy, Nemany A. N., et al.
Publicado: (2023)